• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蝎酸盐难以捉摸的生物活性:癌症治疗的有用支架?

The Elusive Biological Activity of Scorpionates: A Useful Scaffold for Cancer Therapy?

作者信息

Petrosian Artem, Pinheiro Pedro F, Ribeiro Ana P C, Martins Luísa M D R S, Justino Gonçalo C

机构信息

Centro de Química Estrutural-Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1, 1049-001 Lisboa, Portugal.

Escola Superior de Tecnologia do Barreiro, Instituto Politécnico de Setúbal, Rua Américo da Silva Marinho, 2839-001 Lavradio, Portugal.

出版信息

Molecules. 2024 Nov 30;29(23):5672. doi: 10.3390/molecules29235672.

DOI:10.3390/molecules29235672
PMID:39683831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11643361/
Abstract

Cancer remains a formidable challenge, requiring the constant pursuit of novel therapeutic agents and strategies. Scorpionates, known for their unique coordination properties, have recently gained attention for their anticancer potential. Traditionally applied in catalysis, these compounds have demonstrated notable cytotoxicity across various cancer cell lines, often surpassing the efficacy of conventional chemotherapeutics. This review addresses recent findings on scorpionate complexes, emphasizing the impact of metal choice and ligand design on biological activity. Copper and ruthenium scorpionates show promise, leveraging redox activity and mitochondrial disruption mechanisms to selectively induce cancer cell death. Ligand modifications, including sulfur-containing heterocycles and unsubstituted pyrazoles, have proven effective in enhancing cytotoxicity and selectivity. Furthermore, dipodal ligands show unique potential, with selective binding sites that improve stability and facilitate specific cellular interactions, such as targeting metastatic pathways. These findings highlight the largely unexplored potential of scorpionate complexes, positioning them as candidates for next-generation anticancer therapies. Continued research into structure-activity relationships and precise mechanisms of action could pave the way for developing highly potent and selective anticancer agents based on scorpionate chemistry.

摘要

癌症仍然是一项艰巨的挑战,需要不断探索新型治疗药物和策略。蝎形化合物以其独特的配位特性而闻名,最近因其抗癌潜力而受到关注。这些化合物传统上应用于催化领域,已在多种癌细胞系中显示出显著的细胞毒性,其疗效往往超过传统化疗药物。本综述阐述了蝎形配合物的最新研究成果,重点强调了金属选择和配体设计对生物活性的影响。含铜和钌的蝎形化合物显示出应用前景,它们利用氧化还原活性和线粒体破坏机制选择性地诱导癌细胞死亡。包括含硫杂环和未取代吡唑在内的配体修饰已被证明能有效增强细胞毒性和选择性。此外,双齿配体显示出独特的潜力,其选择性结合位点可提高稳定性并促进特定的细胞相互作用,如靶向转移途径。这些发现凸显了蝎形配合物在很大程度上尚未被探索的潜力,使其成为下一代抗癌疗法的候选药物。对构效关系和精确作用机制的持续研究可能为基于蝎形化学开发高效、选择性抗癌药物铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/327429b7d301/molecules-29-05672-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/6850da63d20d/molecules-29-05672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/3e43413d4a81/molecules-29-05672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/0d7554f26c84/molecules-29-05672-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/8404cc455bdc/molecules-29-05672-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/099d052ed24f/molecules-29-05672-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/124b950e54a4/molecules-29-05672-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/327429b7d301/molecules-29-05672-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/6850da63d20d/molecules-29-05672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/3e43413d4a81/molecules-29-05672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/0d7554f26c84/molecules-29-05672-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/8404cc455bdc/molecules-29-05672-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/099d052ed24f/molecules-29-05672-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/124b950e54a4/molecules-29-05672-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d32/11643361/327429b7d301/molecules-29-05672-g007.jpg

相似文献

1
The Elusive Biological Activity of Scorpionates: A Useful Scaffold for Cancer Therapy?蝎酸盐难以捉摸的生物活性:癌症治疗的有用支架?
Molecules. 2024 Nov 30;29(23):5672. doi: 10.3390/molecules29235672.
2
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.采用 2,2'-联吡啶、氨基酸和一氧化氮衍生物的混合配体钌(II)配合物作为潜在抗癌药物提高乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
3
Anticancer metallodrugs: where is the next cisplatin?抗癌金属药物:下一个顺铂在哪里?
Future Med Chem. 2018 Mar 1;10(6):615-617. doi: 10.4155/fmc-2017-0317. Epub 2018 Feb 7.
4
Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.具有取代羟基喹啉的抗癌钌(II)配合物的构效关系。
Eur J Med Chem. 2018 Aug 5;156:790-799. doi: 10.1016/j.ejmech.2018.04.044. Epub 2018 Apr 30.
5
Metal Complexes in Cancer Treatment: Journey So Far.癌症治疗中的金属配合物:迄今的历程
Chem Biodivers. 2023 Apr;20(4):e202300061. doi: 10.1002/cbdv.202300061. Epub 2023 Mar 13.
6
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.铂、钯、金和钌配合物作为抗癌剂:当前临床应用、细胞毒性研究及未来展望。
Eur J Med Chem. 2017 Dec 15;142:8-31. doi: 10.1016/j.ejmech.2017.04.007. Epub 2017 Apr 18.
7
Novel Chemotherapeutic Agents - The Contribution of Scorpionates.新型化疗药物 - 蝎毒素的贡献。
Curr Med Chem. 2019;26(41):7452-7475. doi: 10.2174/0929867325666180914104237.
8
Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.含咪唑钌配合物的光暗激活细胞毒性研究进展
Mini Rev Med Chem. 2016;16(4):272-89. doi: 10.2174/1389557516666151120120524.
9
Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.钌配合物:癌症治疗金属药物开发的新兴领域。
Mini Rev Med Chem. 2016;16(10):772-86. doi: 10.2174/1389557515666151001142012.
10
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.与碳、氮和氧配体配位的(芳烃)钌(II)配合物的抗癌活性及作用方式
Mini Rev Med Chem. 2016;16(10):804-14. doi: 10.2174/138955751610160503004623.

本文引用的文献

1
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.细胞锌代谢和锌信号转导:从生物学功能到疾病和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):6. doi: 10.1038/s41392-023-01679-y.
2
Exploring the Mechanisms behind the Anti-Tumoral Effects of Model C-Scorpionate Complexes.探究模型 C-星状配体配合物抗肿瘤作用的机制。
Molecules. 2023 Jul 17;28(14):5451. doi: 10.3390/molecules28145451.
3
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.
癌症化疗及其他:当前状况、候选药物、相关风险以及靶向治疗的进展。
Genes Dis. 2022 Mar 18;10(4):1367-1401. doi: 10.1016/j.gendis.2022.02.007. eCollection 2023 Jul.
4
Paraptosis: a unique cell death mode for targeting cancer.副凋亡:一种针对癌症的独特细胞死亡模式。
Front Pharmacol. 2023 Jun 15;14:1159409. doi: 10.3389/fphar.2023.1159409. eCollection 2023.
5
Cytotoxicity and mechanism of action of metal complexes: An overview.金属配合物的细胞毒性和作用机制:概述。
Toxicology. 2023 Jun 15;492:153516. doi: 10.1016/j.tox.2023.153516. Epub 2023 Apr 20.
6
Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Management.基于膦和双(吡唑-1-基)乙酸酯配体的酯衍生物的新型银配合物靶向 TrxR:与小细胞肺癌治疗相关的有前途的新型化疗工具。
Int J Mol Sci. 2023 Feb 17;24(4):4091. doi: 10.3390/ijms24044091.
7
Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces.癌症干细胞中的药物与凋亡抗性:一个由诸多碎片组成的谜题。
Cancer Drug Resist. 2022 Aug 2;5(4):850-872. doi: 10.20517/cdr.2022.20. eCollection 2022.
8
Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligands.含生物活性共配体的抗癌钌(II)三(吡唑基)甲烷配合物。
Dalton Trans. 2022 Nov 15;51(44):17050-17063. doi: 10.1039/d2dt03009h.
9
Molecular targeted therapy for anticancer treatment.用于抗癌治疗的分子靶向治疗。
Exp Mol Med. 2022 Oct;54(10):1670-1694. doi: 10.1038/s12276-022-00864-3. Epub 2022 Oct 12.
10
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.癌症化疗:对细胞及肿瘤微环境作用机制的见解
Front Oncol. 2022 Jul 29;12:960317. doi: 10.3389/fonc.2022.960317. eCollection 2022.